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RESEARCH ARTICLE
Survival Analysis for White Non-Hispanic Female Breast
Cancer Patients
Hafiz Mohammad Rafiqullah Khan1*, Anshul Saxena2, Kemesha Gabbidon2,
Tiffanie Shauna-Jeanne Stewart3, Chintan Bhatt4
Abstract
Background: Race and ethnicity are significant factors in predicting survival time of breast cancer patients. In
this study, we applied advanced statistical methods to predict the survival of White non-Hispanic female breast
cancer patients, who were diagnosed between the years 1973 and 2009 in the United States (U.S.). Materials
and Methods: Demographic data from the Surveillance Epidemiology and End Results (SEER) database were
used for the purpose of this study. Nine states were randomly selected from 12 U.S. cancer registries. A stratified
random sampling method was used to select 2,000 female breast cancer patients from these nine states. We
compared four types of advanced statistical probability models to identify the best-fit model for the White nonHispanic female breast cancer survival data. Three model building criterion were used to measure and compare
goodness of fit of the models. These include Akaike Information Criteria (AIC), Bayesian Information Criteria
(BIC), and Deviance Information Criteria (DIC). In addition, we used a novel Bayesian method and the Markov
Chain Monte Carlo technique to determine the posterior density function of the parameters. After evaluating
the model parameters, we selected the model having the lowest DIC value. Using this Bayesian method, we
derived the predictive survival density for future survival time and its related inferences. Results: The analytical
sample of White non-Hispanic women included 2,000 breast cancer cases from the SEER database (1973-2009).
The majority of cases were married (55.2%), the mean age of diagnosis was 63.61 years (SD = 14.24) and the
mean survival time was 84 months (SD = 35.01). After comparing the four statistical models, results suggested
that the exponentiated Weibull model (DIC= 19818.220) was a better fit for White non-Hispanic females’ breast
cancer survival data. This model predicted the survival times (in months) for White non-Hispanic women after
implementation of precise estimates of the model parameters. Conclusions: By using modern model building
criteria, we determined that the data best fit the exponentiated Weibull model. We incorporated precise estimates
of the parameter into the predictive model and evaluated the survival inference for the White non-Hispanic
female population. This method of analysis will assist researchers in making scientific and clinical conclusions
when assessing survival time of breast cancer patients.
Keywords: Breast cancer survival data - statistical probability models - Bayesian inference - predictive inference
Asian Pac J Cancer Prev, 15 (9), 4049-4054

Introduction
Cancer accounts for approximately 20% of all cause
specific mortality in the world (WHO, 2013a). Cancer
has been identified as the predominant cause of death in
developed nations and is also the second most common
cause of death in developing nations due to limited
resources (Jemal et al., 2011).
Nearly 32.6 million people were diagnosed with
cancer in the past 5 years prior to 2012. In the same year,
14.1 million were diagnosed as new cancer cases, and an
estimated 8.2 million people died due to cancer. Among
these, female breast cancer accounted for nearly 522,000
deaths and 1.67 million new cases. Responsible for nearly

14.3% of all cancer related deaths worldwide, breast
cancer is also the most fatal cancer among females aged
between 20-59 (Ferlay et al., 2013; WHO, 2013b).
Globally, the projections for new breast cancer cases
in the year 2020 indicate an increase of 18%; and in the
United States, a 14.4% increase is projected (Ferlay et al.,
2013). It has been suggested that during the year 2000
to 2009, the overall annual percentage change (APC)
in breast cancer incidence has increased in the U.S. For
women aged 40-49, most racial and ethnic groups showed
an overall APC increase of 1.1% (p<0.001) (Hou and Huo,
2013).
Breast cancer incidence is increasing among women
in the U.S. In the year 2012, an estimated 226,870 new
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breast cancer cases and 39,510 deaths occurred due to
the breast cancer (ACS, 2013; Siegel et al., 2014). In
the year 2010, breast cancer patients in the U.S. spent
around $16.5 billion in care and medical services; which
is approximately 13% of the total estimated national
expenditure on cancer care. It is projected that this figure
will reach $23.34 billion in the year 2020, and is going
to be the second largest expenditure in medical care for
cancer (Mariotto et al., 2011; Montero et al., 2012). About
14% of women in the U.S. are expected to develop breast
cancer in their lifetime and the associated costs of care will
affect their survival (ACS, 2013). Among these women,
breast cancer affects ethnicities at different rates (DeSantis
et al., 2011). A higher incidence of 417 cases per 100,000
is reported among White females compared to other racial
groups (White et al., 2013).
The survival of breast cancer patients also depends
on factors such as genetics, age at diagnosis, stage of the
cancer, access to care, weight, physical activity status,
alcohol consumption, disease co-morbidities, social,
economic, environmental factors, and ethnicity (Graeser
et al., 2009; Kwan et al., 2010; Protani et al., 2010; Peairs
et al., 2011; Sprague et al., 2011; ACS, 2013). Screening
guidelines have also evolved based on the research
findings correlating breast cancer-screening and survival
times. Presently, it is recommended that women between
ages 20 to 39 complete a clinical breast examination (CBE)
every 3 years. Those who are asymptomatic but aged 40
years or older are recommended to receive CBE every
year (Robertson et al., 2011; Smith et al., 2013). Women
who have a history of breast cancer in their families should
start screening on a regular basis before age 40. The
most recognizable signs and symptoms of breast cancer
often appear in the later stages of the disease, making it
imperative to detect, diagnose, and treat breast cancer
early (Walker et al., 2013).
The Centers for Disease Control and Prevention
(CDC) has identified that between the years 1999-2010,
White women accounted for the highest incidence of
breast cancer and the third highest mortality rates from
the disease (CDC, 2012). However, White women have
a higher five-year survival rate when compared to other
racial groups. Death rates among White women have
declined 2% from 1997 to 2007; this decline is not found
in other racial or ethnic groups (DeSantis et al., 2011).
Research shows that White women, older than age 40 had
higher rates of breast cancer compared to black women in
the same age group (Clarke et al., 2012).
According to the American Cancer Society, the
incidence of age-adjusted breast cancer vary greatly from
state to state for example, they may range from 47.79 cases
per 100,000 in Connecticut to 20.25 cases in rural Georgia,
the death rates range from 27.6 per 100,000 in Alaska to
17.5 per 100,000 in New Hampshire (ACS, 2013). The
contrast in incidence and mortality rates among race,
ethnicity and other determinants demonstrate a need for
statistical modeling to predict the survival times. Patients
diagnosed with breast cancer, visit clinics, healthcare
units, and hospitals to receive modern treatments to
improve their prognosis. Advancements in modern
technology are able to help patients determine survival
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days. In addition, there is a huge demand for new uses of
statistical analyses in order to facilitate new discoveries,
diagnosis, and treatment planning.
The objectives of this paper are: i) to analyze
demographic variables of the selected sample; ii) to
demonstrate that the breast cancer survival data follows
a specific probability model by using model selection
criterions for goodness of fit tests; iii) to perform the
Bayesian analysis of the posterior distribution for the
parameters; and iv) to derive Bayesian survival inference
for future times by using the best fit model.

Materials and Methods
We used breast cancer data (N=657,712) from
Surveillance, Epidemiology and End Results website
(SEER, 2010). The data contains information for breast
cancer patients from 1973 to 2009, and covers 12 cancer
registries among the 50 U.S. states. A stratified random
sampling method was used to select nine of the 12
available states to provide a representative sample of
White non-Hispanic categories (Figure 1). The total SEER
data included 4,269 males and 653,443 females. Among
the 608,032 total females, 22,639 were White Hispanic,
and 531,562 were White non-Hispanic. Men were not
included in this study due to the small chance (0.70% of
total patients) of breast cancer occurring within this group.
Selected patients and their demographic characteristics
A random sample of 2,000 White non-Hispanic cancer
cases was included in the data analysis representing nine
states in the U.S. (Figure 1). Simple random sampling
(SRS) methodology was used to select a representative
sample of patients and to minimize selection bias.
Health care professionals use various statistical
probability modeling techniques to determine the
prognosis of cancer patients. Often times the data stored
in various cancer registries or databases are utilized.
Survival data taken from these databases follow several
statistical probability models, for example exponential,
Weibull, Exponentiated Exponential (EE), Exponentiated
Weibull (EW), Beta Generalized Exponential (BGE), Beta
inverse Weibull (BIW) model, among others. For accurate
predictions, it is imperative that the data fit the appropriate
model. Different racial and ethnic groups may follow
different distribution patterns and so it is important to use

Figure 1. White Non-Hispanic Breast Cancer Cases
(n=2,000) Randomly Selected from the Nine States
(darker blue color represents the selected states)
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statistical methodologies to draw clinical inferences.
Khan et al. (2014a), discussed in details four types
of statistical probability models. These models include
EEM, EWM, BGEM, and BIW, which were briefly used
in this study. There are two parameters, shape (α>0) and
scale (λ>0) for the EEM (Khan et al. 2014b). The Weibull
model has three parameters, α>0 and β>0 are the shape
parameters, and λ>0 is the scale parameter (Khan et al.
2014c). The beta generalized exponential model has
four parameters, where the shape parameter, α>0 and
the scale parameter, λ>0, and additional two parameters,
a>0 and b>0 are essential for varying tail weight and to
present skewness (Barreto-Souza et al., 2010). The beta
inverse-Weibull (BIW) model is another type of statistical
probability model, where β is the shape parameter, and
two extra parameters, a>0 and b>0, are used to introduce
skewness and tail weight (Khan et al. 2014c, 2014d).
In exploration of the posterior probability for the
parameters from the EEM, BGEM, EWM and BIWM,
an innovative Bayesian method may be used to achieve
posterior inference. In the healthcare research field,
Bayesian statistics have become more popular because
of its use of parametric and model-based inference,
and its applicability to clinical diagnostics, potentially
improving the field of translational research. Data and
model parameters are random variables in the Bayesian
estimation technique; data is termed as “observed” and
parameters are termed as “unobserved” variables. The
joint distribution of the posterior parameters is determined
by multiplication of the likelihood and prior. The
likelihood relies on the model of underlying process given
any values for parameters, it is measured as a conditional
distribution that specifies the probability of the observed
data. Prior and likelihood combine all the available
information about the parameters, and manipulates the
joint distribution in many ways and makes inference about
the parameters given the data. Given a set of observed data,
the Bayesian inference develops the posterior distribution
for the parameters which allows population predictions
when applied to datasets. For more information regarding
Bayesian method and its inference, the readers are referred
to other works (Khan et al., 2012a; 2012b; 2013a; 2013b).
SPSS software (IBM SPSS, 2011) was used to gather
descriptive statistics. Nine out of 12 states were used to
extract data and a geographic map was drawn for White
non-Hispanic women cases using the Google fusion
table (Gonzalez et al., 2010). Mathematica version 8.0
(Wolfram Research, 2012), an advanced computational
software produced a graphical representation of the
predictive density for a single future survival time for
the selected sample. Furthermore, it was used to obtain
additional predictive inferences for the survival times. To
assess goodness of fit, summary results of the posterior
parameters, and to execute related calculations WinBugs
software (MRC Biostatistics Unit, 2013) was used.

Results
Frequency of the sample of breast cancer cases ranged
from 366 (Connecticut) to 25 (Hawaii), and thus the
percentage of White non-Hispanic females with breast

cancer cases in the analysis varied from 1.3% to 18.3%
for various states (Table 1). The second highest percentage
of selected patients was observed from Washington and
the next highest from Michigan.
The quartiles for the mean age at diagnosis were 52,
63, and 75 years, respectively (Table 2). The mean and
median age at diagnosis were close and suggested an
approximate normal distribution. The median survival
time was 87 months and ranged between 38-160 months
for White non-Hispanic females. The majority of the
females in the analytical sample were married (55%).
Best fit survival model and its parameters
Khan et al. (2014b) discussed in details about three
model selection criteria; Akaike Information Criterion
(AIC), Deviance Information Criterion (DIC), and
Bayesian Information Criterion (BIC). The DIC, a measure
of fit is widely used for the comparison of different models.
The Markov Chain Monte Carlo (MCMC) method is
used to attain the posterior distribution of parameters
for the sample. The DIC values can be either positive
or negative, however, the model with smaller values is
considered better than those with larger values. As with
DIC and AIC, the model containing the lower Bayesian
Information Criterion (BIC) values is considered better
between any two estimated models. Bayesian Information

Table 1. Frequency Distribution of Nine Selected States
for White Non-Hispanic Breast Cancer Cases
States
Georgia
Hawaii
Iowa
Michigan
New Mexico
Utah
Washington
California
Connecticut
Total

White non-Hispanic female
Frequency %
148
25
278
327
96
139
348
273
366
2,000

7.4
1.3
13.9
16.3
4.8
7
17.4
13.6
18.3
100

Table 2. Descriptive Statistics for White Non-Hispanic
Breast Cancer Cases
Characteristics
Categories
		
Age at diagnosis (years)

Mean
SD
Median
Range
Quartile (Q1, Q2 and Q3)
Variance
Survival time (months)
Mean
SD
Median
Range
Quartile (Q1, Q2 and Q3)
Variance
Marital status at diagnosis Single
Married
Separated
Divorced
Widowed
Unknown

White
non-Hispanic
63.31
14.24
63
15-104
52, 63 and 75
202.74
84.17
35.01
87
38-160
60, 87 and 118
1225.5
182
1103
29
153
464
69
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Criterion (BIC) is an asymptotic result assumed that the
distribution of data is an exponential family.
We used log-likelihood function of the models in
WinBugs (MRC Biostatistics Unit, 2013) and applied
them for White non-Hispanic survival data. The AIC, BIC,
and DIC values are calculated and the summary results of
the measures of goodness of fits are reported in Table 3.
Table 3 consists of AIC, BIC, and DIC values for the
EE, EW, BGE, and BIW models. Comparing the estimated
values of all AIC, BIC, and DIC for the models, the EWM
fits better for the survival times because it produces the
smallest values of AIC and DIC.
Table 4 presents the summary results (Mean, SD, MC
Error, Median, and Confidence Intervals) of the parameters
in the case of best-fit exponentiated Weibull model for
White non-Hispanic female breast cancer cases.
Figure 2 displays the graphical representation of the
parameters. It is noted that all the parameters produced
skewed distributions. Parameter values when plotted
showed that alpha and beta are negatively skewed, and
lambda is positively skewed. The range (95% CI) of these
parameter values are described in Table 4. After 50,000
iterations, the kernel density appears smoothened.

Survival inference
We developed a predictive survival model using the
results of the best-fit model to demonstrate the survival
time of White non-Hispanic women with breast cancer
patients. By using the values of model selection criterion
found in Table 3, it is identified that the data follows the
exponentiated Weibull model. Applying the Bayesian
survival model, we assume the data set x=(x1, . . . , xn)
represent n White non-Hispanic female breast cancer cases
survival days that follow the exponentiated Weibull model,
and let y be a future survival time, then following Khan et
al. (2011), the predictive density of y given the observed
White non-Hispanic survival data x, is given by p(y | x) =
∫∫∫ p(y |α, β, λ) p(α, β, λ | x) dλ dβ dα, where, p(α, β, λ | x) is
the posterior density function, and p(y | α, β, λ) represents
the probability density function for a future survival time
(y) that is defined from the best fit exponentiated Weibull
model.
Graphical representation of the predictive density is
shown in Figure 3 based on the survival times of White
non-Hispanic cases.
Figure 3 presents the predictive survival density
function. The predictive density (Figure 3) for the survival

Table 3. Selection of the Models for White NonHispanic Females on the Basis of AIC, BIC, and DIC
Criterions
Model criterions

AIC

Exponentiated exponential
Exponentiated Weibull
Beta generalized exponential
Beta inverse Weibull

19826.4
19821.7
19828.5
19866.3

BIC
19837.001
19838.102
19850.903
19883.102

DIC
19826.378
19818.22
19824.524
19860.298

Table 4. Summary Results of the Posterior Parameters
in the Case of Exponentiated Weibull for White NonHispanic Females Breast Cancer Cases (n=2,000;
sample=50,000)
Node

Mean

Alpha 7.25
Beta
1.092
Lambda 0.0189

SD

MC error Median

0.1189
0.00643
5.34E-04

95% CI

0.001082 7.28
(6.949, 7.385)
1.74E-04 1.093 (1.076, 1.101)
1.49E-05 0.01875 (0.01833, 0.02031)

Table 5. Future Inference Based on the EWM for White
Non-Hispanic Breast Cancer Cases Survival Data
Summary

Raw moments

Corrected moments

Skewness & Kurtosis

Survival intervals

4052

Mean
Standard Error
m1
m2
m3
m4
m1
m2
m3
m4
b1
b2
g1
g2
90%
95%
98%
99%

White non-Hispanic
90.836
0.860919
90.836
9733.54
1.214115106
1.737385108
90.836
1482.36
60649.6
1.023165107
1.12925
4.65624
1.06266
1.65624
(33.6239, 156.1253)
(28.6290, 170.4252)
(19.9019, 200.7740)
(15.6533, 219.8770)
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Figure 2. Kernel Density of the Posterior Parameters
in the Case of Exponentiated Weibull for White NonHispanic Females Breast Cancer Cases (n=2,000)

Figure 3. Predictive Density for White Non-Hispanic
Female Breast Cancer Patient’s Survival Data
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None

Remission

Persistence or recurrence

Newly diagnosed with treatment

Newly diagnosed without treatment

times appears to be unimodal and it is positively skewed,
to the results, the shape of the future survival model for
ranging from 28.629 to 170.4252 (95% CI).
White non-Hispanic women is positively skewed.
Table 5 contains summary statistics for future survival
Figure 3 shows the graphical representations of
times of the patients. We identified that the survival times
White non-Hispanic female future survival times using
are higher for future patients compared with existing
the exponentiated Weibull distribution in the Bayesian
diagnosed patients. We obtained the raw and corrected
method. Higher survival times are identified for White
moments for the survival inference for future White nonnon-Hispanic women compared to the existing survival
Hispanic female breast cancer patients. Since Kurtosis is
times. For ethnicity, we report the predictive raw and
<3, we can assume that the future survival values follow
corrected moments, predictive skewness, and kurtosis for
a platykurtic distribution. The data points represent a flat
future survival time in Table 5. The model is able to predict
100.0survival times accurately within 90%-99% confidence
100.0
distribution as compared to a normal distribution, which
has a wider peak. Since Skewness is >0, majority of the
intervals6.3
while taking
multiple parameters.
10.1into account
20.3
data falls to the left of the mean, with extreme values to
We identified a data-based statistical probability model
the right.
from the 1973-2009 SEER database to25.0
demonstrate the 30.0
75.0
75.0
effectiveness of predicting breast cancer survival data
for White non- Hispanic
women. Statistical probability
Discussion
46.8
56.3
models are important for posterior model parameters in
For White non-Hispanic women diagnosed with breast50.0order to predict survival times
54.2
among 31.3
ethnicity and for50.0
30.0
cancer between the years 1973 to 2009 in the U.S., several
describing inferences for observations. To best determine
statistical models were used to show the best-fit for the
a fitted model, methods for measuring the goodness of fit
breast cancer survival data. The sample consisted of 2,000
tests are imperative in the selection of the best statistical
White non-Hispanic women; stratified random sampling25.0probability models for survival samples of ethnicity. AIC,25.0
38.0
31.3
31.3
30.0
was used at the state level and simple random sampling
BIC, and DIC model selection
23.7criterions were used to
used within the nine states.
develop statistical probability model for ethnicity.
The Mean (SD), age (in years) at diagnosis for breast 0 These findings will be beneficial to healthcare 0
cancer cases was 63.31 (14.24), with age 15 being the
researchers and practitioners to aid in the prediction
minimum age at diagnosis for White non-Hispanic
of a patient’s possible survival time given the patient’s
women. The highest mortality rates among women
current state and medical history. Therefore, the findings
diagnosed with breast cancer are those that are 50 years
may work to improve knowledge, demonstrate scientific
or older (SEER, 2010). Survival time ranged from 38 to
discovery, and innovation. This may improve the diagnosis
160 months, with a Mean (SD), 84.17 (35.01) months.
and treatment of breast cancer cases within the United
The majority of these cases were married.
States and the world.
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parameters and to draw their corresponding dynamic
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